Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14804
ชื่อเรื่อง: Bilateral acute onset myopia and angle closure glaucoma after oral topiramate: A case report
ผู้แต่ง: Boonyaleephan S.
Keywords: acetazolamide
amitriptyline
antiglaucoma agent
glycerol
mefenamic acid
prednisolone acetate
propranolol derivative
timolol maleate
topiramate
acetazolamide
anticonvulsive agent
antihypertensive agent
cryoprotective agent
drug derivative
fructose
glycerol
timolol
topiramate
adult
anterior eye chamber
article
biomicroscopy
blurred vision
case report
chemosis
closed angle glaucoma
cornea edema
drug withdrawal
eye examination
eye pain
eye refraction
female
human
intraocular pressure
migraine
myopia
photography
side effect
visual acuity
acute disease
chemically induced disorder
closed angle glaucoma
drug effect
myopia
risk factor
Acetazolamide
Acute Disease
Adult
Anticonvulsants
Antihypertensive Agents
Cryoprotective Agents
Female
Fructose
Glaucoma, Angle-Closure
Glycerol
Humans
Intraocular Pressure
Myopia
Risk Factors
Timolol
วันที่เผยแพร่: 2008
บทคัดย่อ: Objective: Describe bilateral acute onset myopia and angle-closure glaucoma as ocular adverse effects of topiramate. Case Report: A 23 year-old woman developed bilateral severe blurred vision seven days after initiating therapy with topiramate. Her visual acuity was counting fingers in both eyes. Intraocular pressures were 33 mmHg and 32 mmHg in the right and left eyes, respectively, with conjunctival chemosis, corneal edema, shallow anterior chambers, and closed angles. Her refraction was -7.50 diopters in both eyes. The symptoms and clinical findings resolved completely upon discontinuation of topiramate and administration of antiglaucoma drugs. Conclusion: Topiramate use can result in acute bilateral angle-closure glaucoma and myopia, which are usually reversible upon cessation of the drug. Visual outcome is usually good and the episode resolves within a few weeks. Thus, it is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.
URI: https://ir.swu.ac.th/jspui/handle/123456789/14804
https://www.scopus.com/inward/record.uri?eid=2-s2.0-58949090429&partnerID=40&md5=2fd3b1ec03ed2ea01f81dd35fadb3257
ISSN: 1252208
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.